{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T17:15:44Z","timestamp":1758388544239,"version":"3.44.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["812490","813279"],"award-info":[{"award-number":["812490","813279"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jpsychires.2023.04.007","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T12:01:23Z","timestamp":1681128083000},"page":"65-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Assessment of cognitive impairment and depressive signs in patients with type 2 diabetes treated with metformin from Southeast Mexico: A cross-sectional study"],"prefix":"10.1016","volume":"162","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5536-3173","authenticated-orcid":false,"given":"German Alberto","family":"Nolasco-Rosales","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo Efr\u00e9n","family":"Villar-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Arturo","family":"P\u00e9rez-Osorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Daniel","family":"Cruz-Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Molina-Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thelma Beatriz","family":"Gonz\u00e1lez-Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8170-8171","authenticated-orcid":false,"given":"Carlos Alfonso","family":"Tovilla-Z\u00e1rate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"Rodr\u00edguez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alma Delia","family":"Genis-Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filiberto","family":"Hern\u00e1ndez-Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isela Esther","family":"Ju\u00e1rez-Rojop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. ment_1","key":"10.1016\/j.jpsychires.2023.04.007_bib1","first-page":"S125","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes\u20142022","volume":"45","author":"ADA Professional Practice","year":"2021","journal-title":"Diabetes Care"},{"issue":"Suppl. ment_1","key":"10.1016\/j.jpsychires.2023.04.007_bib2","first-page":"S175","article-title":"11. Chronic kidney disease and risk management: standards of medical care in diabetes\u20142022","volume":"45","author":"ADA Professional Practice","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpsychires.2023.04.007_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.849607","article-title":"Diabetes: chronic metformin treatment and outcome following acute stroke","volume":"13","author":"Akhtar","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jpsychires.2023.04.007_bib4","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.73138","article-title":"Type 2 diabetes mellitus accelerates brain aging and cognitive decline: complementary findings from UK Biobank and meta-analyses","volume":"11","author":"Antal","year":"2022","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.jpsychires.2023.04.007_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1076\/anec.11.1.1.29366","article-title":"Validation of a modified version of the mini-mental state examination (MMSE) in Spanish","volume":"11","author":"Beaman","year":"2004","journal-title":"Aging Neuropsychol. Cognit."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.04.007_bib6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40801-022-00321-7","article-title":"Associations of cardiovascular agents and metformin with depression symptoms: a cross-sectional analysis from the HUNT study, Norway","volume":"9","author":"Bojani\u0107","year":"2022","journal-title":"Drugs - Real World Outcomes"},{"key":"10.1016\/j.jpsychires.2023.04.007_bib7","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3233\/JAD-180263","article-title":"Metformin use associated with reduced risk of dementia in patients with diabetes: a systematic review and meta-analysis","volume":"65","author":"Campbell","year":"2018","journal-title":"J. Alzheim. Dis."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.04.007_bib8","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1186\/s12889-019-7392-y","article-title":"Risk factors for depression in elderly diabetic patients and the effect of metformin on the condition","volume":"19","author":"Chen","year":"2019","journal-title":"BMC Publ. Health"},{"issue":"9","key":"10.1016\/j.jpsychires.2023.04.007_bib9","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamaneurol.2020.1840","article-title":"Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and alzheimer disease dementia: a randomized clinical trial","volume":"77","author":"Craft","year":"2020","journal-title":"JAMA Neurol."},{"issue":"11","key":"10.1016\/j.jpsychires.2023.04.007_bib10","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/alz.12482","article-title":"The impact of diabetes on cognitive impairment and its progression to dementia","volume":"17","author":"Dove","year":"2021","journal-title":"Alzheimer's Dementia"},{"issue":"3","key":"10.1016\/j.jpsychires.2023.04.007_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"issue":"9","key":"10.1016\/j.jpsychires.2023.04.007_bib12","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/1440-1681.12265","article-title":"Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus","volume":"41","author":"Guo","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"8","key":"10.1016\/j.jpsychires.2023.04.007_bib13","article-title":"Metformin for the improvement of comorbid depression symptoms in diabetic patients: a systematic review","volume":"14","author":"Hamal","year":"2022","journal-title":"Cureus"},{"issue":"8","key":"10.1016\/j.jpsychires.2023.04.007_bib14","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/pon.5129","article-title":"The effects of weight loss and metformin on cognition among breast cancer survivors: evidence from the Reach for Health study","volume":"28","author":"Hartman","year":"2019","journal-title":"Psycho Oncol."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.04.007_bib15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.04.007_bib16","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3892\/etm.2015.2593","article-title":"Pioglitazone is an effective treatment for patients with post-stroke depression combined with type 2 diabetes mellitus","volume":"10","author":"Hu","year":"2015","journal-title":"Exp. Ther. Med."},{"year":"2021","series-title":"IDF Diabetes Atlas","key":"10.1016\/j.jpsychires.2023.04.007_bib17"},{"issue":"2","key":"10.1016\/j.jpsychires.2023.04.007_bib18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ddr.21579","article-title":"Cognitive dysfunction: a growing link between diabetes and Alzheimer's disease","volume":"81","author":"Jash","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.jpsychires.2023.04.007_bib19","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3233\/JAD-180413","article-title":"Role of the glyoxalase system in alzheimer's disease","volume":"66","author":"Jiang","year":"2018","journal-title":"J. Alzheim. Dis."},{"issue":"6","key":"10.1016\/j.jpsychires.2023.04.007_bib20","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.psyneuen.2012.08.010","article-title":"Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression","volume":"38","author":"Kashani","year":"2013","journal-title":"Psychoneuroendocrinology"},{"issue":"9","key":"10.1016\/j.jpsychires.2023.04.007_bib21","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","article-title":"Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches","volume":"19","author":"Kellar","year":"2020","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.04.007_bib22","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/s41598-022-05165-3","article-title":"Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer's disease: a randomized trial","volume":"12","author":"Kellar","year":"2022","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.jpsychires.2023.04.007_bib23","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.2337\/dc20-1561","article-title":"Antidiabetes agents and incident depression: a nationwide population-based study","volume":"43","author":"Kessing","year":"2020","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.jpsychires.2023.04.007_bib24","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00592-019-01295-9","article-title":"The prevalence of comorbid depression in patients with type 2 diabetes: an updated systematic review and meta-analysis on huge number of observational studies","volume":"56","author":"Khaledi","year":"2019","journal-title":"Acta Diabetol."},{"issue":"2","key":"10.1016\/j.jpsychires.2023.04.007_bib25","doi-asserted-by":"crossref","DOI":"10.1097\/WAD.0000000000000202","article-title":"Effects of the insulin sensitizer metformin in alzheimer disease: pilot data from a randomized placebo-controlled crossover study","volume":"31","author":"Koenig","year":"2017","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.jpsychires.2023.04.007_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3233\/JPD-171285","article-title":"Alpha-synuclein glycation and the action of anti-diabetic agents in Parkinson's disease","volume":"8","author":"K\u00f6nig","year":"2018","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jpsychires.2023.04.007_bib27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fnagi.2018.00227","article-title":"Evaluation of metformin on cognitive improvement in patients with non-dementia vascular cognitive impairment and abnormal glucose metabolism","volume":"10","author":"Lin","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/j.jpsychires.2023.04.007_bib28","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/JAD-150493","article-title":"Metformin in amnestic mild cognitive impairment: results of a pilot randomized placebo controlled clinical trial","volume":"51","author":"Luchsinger","year":"2016","journal-title":"J. Alzheimers. Dis."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.04.007_bib29","article-title":"Promise of metformin for preventing age-related cognitive dysfunction","volume":"17","author":"Madhu","year":"2022","journal-title":"Neural Regenerat. Res."},{"issue":"5","key":"10.1016\/j.jpsychires.2023.04.007_bib30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000510677","article-title":"Antidiabetic drugs in alzheimer's disease and mild cognitive impairment: a systematic review","volume":"49","author":"Mu\u00f1oz-Jim\u00e9nez","year":"2020","journal-title":"Dement. Geriatr. Cognit. Disord."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.04.007_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3233\/JAD-131901","article-title":"Long-term metformin usage and cognitive function among older adults with diabetes","volume":"41","author":"Ng","year":"2014","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.jpsychires.2023.04.007_bib32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jad.2022.04.156","article-title":"Investigating the pro-cognitive and anti-depressant efficacy of metformin: a systematic review and meta-analysis of randomised controlled trials","volume":"310","author":"Nibber","year":"2022","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.jpsychires.2023.04.007_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214364","article-title":"Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: a double-blinded placebo-controlled pilot study","volume":"14","author":"Novak","year":"2019","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.jpsychires.2023.04.007_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212366","article-title":"Diabetes and cognitive impairment: a role for glucotoxicity and dopaminergic dysfunction","volume":"22","author":"Pignalosa","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.04.007_bib35","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/dme.14227","article-title":"How 25 years of psychosocial research has contributed to a better understanding of the links between depression and diabetes","volume":"37","author":"Pouwer","year":"2020","journal-title":"Diabet. Med."},{"issue":"12","key":"10.1016\/j.jpsychires.2023.04.007_bib36","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/alz.12362","article-title":"Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020-2060)","volume":"17","author":"Rajan","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"11","key":"10.1016\/j.jpsychires.2023.04.007_bib37","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.2337\/dc20-0892","article-title":"Metformin use is associated with slowed cognitive decline and reduced incident dementia in older adults with type 2 diabetes: the sydney memory and ageing study","volume":"43","author":"Samaras","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpsychires.2023.04.007_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119343","article-title":"Repurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke","volume":"274","author":"Sharma","year":"2021","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.jpsychires.2023.04.007_bib39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S2213-8587(20)30118-2","article-title":"Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities","volume":"8","author":"Srikanth","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.jpsychires.2023.04.007_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.773797","article-title":"Long-Term use of metformin is associated with reduced risk of cognitive impairment with alleviation of cerebral small vessel disease burden in patients with type 2 diabetes","volume":"13","author":"Teng","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.04.007_bib41","doi-asserted-by":"crossref","DOI":"10.1097\/WAD.0000000000000433","article-title":"Prevalence of mild cognitive impairment in the lothian birth cohort 1936","volume":"35","author":"Welstead","year":"2021","journal-title":"Alzheimer Dis. Assoc. Disord."},{"year":"2019","series-title":"Classification of Diabetes Mellitus","author":"WHO","key":"10.1016\/j.jpsychires.2023.04.007_bib42"},{"issue":"18","key":"10.1016\/j.jpsychires.2023.04.007_bib43","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.3390\/ijms21186969","article-title":"Clinical evidence of antidepressant effects of insulin and anti-hyperglycemic agents and implications for the pathophysiology of depression\u2014a literature review","volume":"21","author":"Woo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.jpsychires.2023.04.007_bib44","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/2396987316666617","article-title":"Impact of pre-stroke sulphonylurea and metformin use on mortality of intracerebral haemorrhage","volume":"1","author":"Wu","year":"2016","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.jpsychires.2023.04.007_bib45","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jad.2022.09.015","article-title":"Association of metformin and depression in patients with type 2 diabetes","volume":"318","author":"Yu","year":"2022","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.jpsychires.2023.04.007_bib46","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11892-016-0775-x","article-title":"Diabetes and cognitive impairment","volume":"16","author":"Zilliox","year":"2016","journal-title":"Curr. Diabetes Rep."},{"issue":"9","key":"10.1016\/j.jpsychires.2023.04.007_bib47","doi-asserted-by":"crossref","DOI":"10.1097\/01.nmd.0000138226.22761.39","article-title":"A review of studies of the Hamilton depression rating scale in healthy controls: implications for the definition of remission in treatment studies of depression","volume":"192","author":"Zimmerman","year":"2004","journal-title":"J. Nerv. Ment. Dis."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395623001711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395623001711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:34:46Z","timestamp":1758368086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395623001711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":47,"alternative-id":["S0022395623001711"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2023.04.007","relation":{},"ISSN":["0022-3956"],"issn-type":[{"type":"print","value":"0022-3956"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of cognitive impairment and depressive signs in patients with type 2 diabetes treated with metformin from Southeast Mexico: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2023.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}